US FDA approves updated COVID vaccines for 2026-27 season

The US FDA has officially approved updated COVID vaccines for the 2026-27 season. This regulatory decision ensures that the latest vaccine formulations are available to the public to maintain protection against evolving strains of the virus. The approval follows standard review processes to verify the safety and efficacy of the updated doses. These vaccines are now cleared for distribution and administration to the population as part of the ongoing public health strategy for the upcoming period.